Is Kybella the Next Big Thing? One Surgeon Shares His Insights and Experience with Kybella
Joe Niamtu III, DMD, shares his insights and experience with Kythera Biopharmaceuticals’ new fat-dissolving injectable Kybella in this August 2015 feature.
Tag: Allergan
All
PopularAll
Latest
Allergan Aesthetics Names Inaugural Faculty for AMI Training Centers
The faculty will guide hands-on training and immersive programs at the AMI Orange County and Atlanta Training Centers.
All
Latest
New Approach Could Help Prevent Scarring After Surgery
Researchers have discovered a naturally occurring protein that could lead to new therapies for preventing excessive scarring in patients during wound healing.
Allergan Aesthetics Enters Into Option to Acquire Cypris Medical
Allergan Aesthetics, an AbbVie company, announces that it has entered into a warrant agreement with Cypris Medical, a privately held, medical device company based in Chicago.
Read More
4 Aesthetic Loyalty Programs Explained
Allergan has revamped its Brilliant Distinctions program so patients earn points on non-Allergan services. Aerolase, Merz, and Synergy also offer loyalty programs to grow your practice.
Read More
Cosmetic Surgery Foundation Welcomes New Members to Industry Advisory Council
The new industry advisory council members, who are senior leaders in the cosmetic surgery business, will be working on projects designed to enhance patient safety and surgical scholarship.
Read More
Second Annual BOTOX Cosmetic Day is November 18
Allergan Aesthetics’ exclusive one-day-only offer for BOTOX Cosmetic patients and healthcare providers to put themselves first.
Read More
Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting
Allergan Aesthetics, an AbbVie company, announces it will present four abstracts at the annual American Society for Dermatologic Surgery (ASDS) virtual meeting from October 9-11, 2020.
Read More
The Makers of Botox Have a New Brand Identity
Allergan Aesthetics, which was acquired by AbbVie earlier this year, announced today that it’s introducing its new global brand identity with the goal of empowering confidence, NewBeauty reports.
Read More
The DREAM Initiative Aims To Advance Health Equity and Diversity in Aesthetics
Allergan Aesthetics and Skinbetter Science announce the launch of a new long-term, educational initiative – DREAM: Driving Racial Equity in Aesthetic Medicine, according to a media release.
Read More
Pent-Up Demand for Aesthetic Services Brings Hordes (Millennials in Particular) to Reopened Practices
Post-procedure patient downtime is less of a concern because the pandemic allows patients to heal privately at home. Some prescription cosmetic neurotoxin makers report record-high demand.
Read More
BTL Files Complaint with the ITC to Prevent the Importing of Products That Infringe on Its Patent
BTL Industries Inc (BTL), manufacturer of the EMSCULPT body-contouring device and other products for non-invasive body-shaping procedures, has filed a complaint with the United States International Trade Commission (ITC), asking the Commission to prevent Allergan Limited, Allergan Inc, Allergan USA Inc, Zeltiq Aesthetics Inc, Zeltiq Ireland Unlimited Company (Allergan), and Zimmer MedizinSysteme GmbH, Germany (Zimmer) from importing products that infringe BTL’s patents into the United States.
Read More
FDA Approves the Chin Filler JUVÉDERM VOLUMA XC from Allergan Aesthetics
Allergan Aesthetics, an AbbVie company, announces the FDA approval of JUVÉDERM VOLUMA XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21.
Read More
Allergan Launches Campaign To Contact Patients Who May Not Be Aware Of The BIOCELL Recall And To Improve Tracking Information For US Breast Implant Patients
Allergan Aesthetics, an AbbVie company, is initiating a new digital campaign to improve device tracking and further identify and reach breast implant patients who have, or have had, BIOCELL breast implants and/or tissue expanders to inform them of the risk of BIA-ALCL.
Read More
Allergan and AbbVie Receive Second Request from Federal Trade Commission on Pending Transaction
Allergan plc announces that, as expected, Allergan and AbbVie have each received a Request for Additional Information and Documentary Material (Second Request) from the US Federal Trade Commission (FTC) in connection with AbbVie’s pending acquisition of Allergan.
Read More
Allergan 360° Aesthetics Report Explores Patients’ Needs and Motivations
The Allergan 360° Aesthetics Report explores the mindset and motivations of aesthetically conscious consumers across a variety of ages, races, cultures and genders, as well as the physicians who treat them.
Read MoreBotox Company Steers Ads Toward Men In Face of More Competition
Allergan Plc is rolling out its first advertising campaign that directly pitches its blockbuster wrinkle-smoothing treatment Botox to men. The campaign will include TV commercials.
Read MoreRevisiting Kybella
Approved in April 2015, Kybella (deoxycholic acid, Allergan) generated a lot of buzz as an injectable treatment to rid adults of their double chins. So what are physicians saying about Kybella three years later?
Read More